Endocrine Pharmacology
Hyperthyroidism is a pathologic state characterized by excessive thyroid hormone production and secretion, resulting in hypermetabolism. Primary etiologies include Graves' disease (autoimmune thyroid-stimulating immunoglobulin-mediated), toxic nodular goiter, and thyroid adenomas. Clinical manifestations reflect increased basal metabolic rate, enhanced sympathetic nervous system activity, and elevated catecholamine sensitivity. Pharmacologic management employs antithyroid drugs to inhibit hormone synthesis, iodine preparations to block hormone release, beta-adrenergic antagonists for symptomatic control, and radioactive iodine or surgery for definitive therapy.
📋 Abbreviations Used in This Article
- TSH: Thyroid-Stimulating Hormone
- TSI: Thyroid-Stimulating Immunoglobulin
- T3: Triiodothyronine
- T4: Thyroxine
- PTU: Propylthiouracil
- RAI: Radioactive Iodine
- SSKI: Saturated Solution of Potassium Iodide
- IV: Intravenous
- CBC: Complete Blood Count
🔬 Pathophysiology and Classification
Hyperthyroidism results from multiple mechanisms of thyroid hormone excess:
Graves' Disease (80% of Cases)
- Mechanism: TSI antibodies stimulate TSH receptors
- Features: Diffuse goiter, ophthalmopathy, pretibial myxedema
- Lab Pattern: Low TSH, elevated free T4 and T3
- Treatment: Antithyroid drugs first-line
Toxic Nodular Disease
- Mechanism: Autonomous hormone production by nodules
- Demographics: Elderly, iodine-deficient areas
- Treatment: RAI or surgery preferred
🎯 Key Concept: Excess thyroid hormones increase basal metabolic rate through enhanced Na+/K+ ATPase activity, mitochondrial oxidative phosphorylation, and catecholamine receptor sensitivity, explaining the hypermetabolic and sympathomimetic clinical presentation.
💊 Pharmacologic Management
Multiple therapeutic modalities target different aspects of thyroid hormone excess:
| Drug Class | Mechanism | Key Agents | Major Adverse Effects |
|---|---|---|---|
| Thionamides | Inhibit thyroid peroxidase, block hormone synthesis | Methimazole, PTU | Agranulocytosis (0.1-0.5%), hepatotoxicity, rash |
| Iodine | Wolff-Chaikoff effect, inhibits hormone release | Lugol's solution, SSKI | Escape phenomenon, hypersensitivity |
| Beta-Blockers | Symptomatic control, blocks peripheral T4 to T3 conversion | Propranolol, atenolol | Bradycardia, bronchospasm |
| Radioactive Iodine | Destroys hyperfunctioning thyroid tissue | I-131 | Hypothyroidism (80-90%), radiation thyroiditis |
🎯 Antithyroid Drugs (Thionamides)
First-line medical therapy for Graves' disease and pre-operative preparation:
Methimazole
- Dosing: 10 to 30 mg daily initially, maintenance 5 to 10 mg daily
- Advantages: Once-daily dosing, longer half-life, fewer adverse effects
- Preferred: Most patients except first trimester pregnancy
Propylthiouracil (PTU)
- Dosing: 100 to 150 mg every 8 hours initially
- Additional Effect: Inhibits peripheral T4 to T3 conversion
- Indications: First trimester pregnancy, thyroid storm
- Risk: Higher hepatotoxicity than methimazole
⚠️ Agranulocytosis Warning: Patients must immediately report fever, sore throat, or mouth ulcers and discontinue medication. Check CBC if symptoms develop. Risk occurs in 0.1% to 0.5% of patients, typically within first 3 months of therapy.
⚡ Adjunctive and Definitive Therapies
Additional pharmacologic agents and definitive treatment modalities:
Beta-Adrenergic Antagonists
- Propranolol: 20 to 40 mg every 6 to 8 hours; also inhibits T4 to T3 conversion
- Atenolol: 25 to 50 mg daily; cardioselective
- Indication: Rapid symptomatic relief of tachycardia, tremor, anxiety
- Duration: Continue until euthyroid state achieved (4 to 8 weeks)
Iodine Preparations
- SSKI: 5 to 10 drops (250 to 500 mg) daily
- Timing: Administer 1 hour after thionamide to prevent organification
- Indications: Thyroid storm, pre-operative preparation, post-RAI adjunct
- Limitation: Escape phenomenon after 2 to 3 weeks
Radioactive Iodine (I-131)
- Mechanism: Selective destruction of hyperfunctioning thyroid tissue
- Dosing: 10 to 15 mCi based on gland size and uptake
- Cure Rate: 80% to 90% with single dose
- Contraindications: Pregnancy, breastfeeding, planning pregnancy within 6 months
- Major Effect: Hypothyroidism occurs in 80% to 90% of patients
🆘 Thyroid Storm Management
Life-threatening medical emergency requiring multi-drug intensive therapy:
Emergency Protocol (Sequential Administration)
- Step 1 - PTU: 500 to 1000 mg loading dose, then 250 mg every 4 hours (preferred for peripheral T3 inhibition)
- Step 2 - Iodine: 1 hour after thionamide; SSKI 5 drops every 6 hours or Lugol's solution 8 drops every 6 hours
- Step 3 - Propranolol: 60 to 80 mg every 4 hours orally or 1 mg IV slowly, then 2 to 3 mg every 4 hours
- Step 4 - Glucocorticoids: Hydrocortisone 100 mg IV every 8 hours or dexamethasone 2 mg IV every 6 hours
- Step 5 - Supportive Care: Cooling, IV fluids, treat precipitating factors
🎯 Special Populations
Critical management considerations for specific patient groups:
| Population | Drug Selection | Key Considerations |
|---|---|---|
| Pregnancy (First Trimester) | PTU preferred | Switch to methimazole second/third trimester; monitor TSH every 4 weeks |
| Pregnancy (Second/Third Trimester) | Methimazole | Goal: Free T4 upper third of normal range |
| Elderly | RAI or beta-blockers first | Higher risk atrial fibrillation, apathetic hyperthyroidism |
| Cardiac Disease | Beta-blockers essential | Rate control, consider anticoagulation if atrial fibrillation |
| Active Ophthalmopathy | Avoid RAI | Use steroids if RAI necessary; smoking cessation crucial |
📊 Monitoring Protocol
Systematic follow-up ensures therapeutic efficacy and safety:
Laboratory Monitoring
- Initial Phase: TSH, free T4 every 4 to 6 weeks
- Baseline Testing: CBC, liver enzymes before starting thionamides
- Symptom-Triggered: CBC if fever, sore throat, or mouth ulcers
- Post-RAI: TSH every 4 to 8 weeks until stable
- Long-Term: Annual TSH once euthyroid and stable
🎯 Clinical Pearls
Essential high-yield principles for hyperthyroidism management:
- Methimazole preferred over PTU except first trimester pregnancy and thyroid storm
- Beta-blockers provide rapid symptomatic relief while awaiting thionamide effect
- Always administer thionamide before iodine to prevent organification of excess iodine
- RAI contraindicated in pregnancy, breastfeeding; causes hypothyroidism in 80% to 90%
- Agranulocytosis risk highest in first 3 months; educate patients on warning signs
- Thyroid storm requires multi-drug therapy: PTU, iodine (1 hour later), propranolol, steroids
- Treatment duration for Graves' disease typically 12 to 18 months with thionamides
- Monitor CBC and liver enzymes at baseline and if symptoms develop
🔬 Pharmacology Study Tips:
- Mechanism distinction: Thionamides inhibit synthesis; iodine inhibits release; beta-blockers control symptoms
- Remember timing: Thionamide first, then iodine 1 hour later (prevents iodine organification)
- Know adverse effects: Agranulocytosis (thionamides), escape phenomenon (iodine), hypothyroidism (RAI)
- Pregnancy drugs: PTU first trimester, methimazole second/third trimester